CSX Corporation vs 22nd Century Group Inc — how do they compare? CSX Corporation trades at $49.5 (market cap $92.24B), while 22nd Century Group Inc trades at $4.19 (market cap $1.45M). The key difference: CSX Corporation is far larger — about 63613.8× 22nd Century Group Inc's market cap, and CSX Corporation pays a 1.13% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| CSX | XXII | |
|---|---|---|
Market Cap | $92.24B | $1.45M |
Sector | Industrials | Technology |
52-Week High | $49.92 | $1.47K |
52-Week Low | $32.05 | $3.90 |
Enterprise Value | $110.47B | -$6.78M |
Dividend Yield | 1.13% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XXII trades at $4.10, down 3.07% today, with a bearish technical signal from moving averages. The company shows severe financial distress with a negative gross profit margin of -52.19% and net income margin of -65.76% for 2025. Recent news highlights expansion of VLN reduced-nicotine cigarettes in California and New York, aiming to capture market share. A 20:1 reverse stock split occurred on June 12, 2026, to adjust share structure.
The outlook remains high-risk due to persistent losses and cash burn, though analyst consensus is 75% buy-rated. Investment opportunity hinges on successful commercialization of VLN products and FDA regulatory renewals. Key risks include execution challenges, intense competition, and reliance on financing to sustain operations amid negative cash flow from operations.
Trailing returns across standard periods
Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.
Read more on CSX →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →